A forodesine-based regimen as a therapeutic option for PTCL-NOS with Central nervous system involvement

Authors :: Naoki Hosen
Kana Matsumoto
Hirohiko Shibayama
Kenji Nozaki
Jiro Fujita
Yukiko Doi
Masako Kurashige
Takafumi Yokota
Kentaro Fukushima
Source :: Leukemialymphoma. 63(4)
Publication Year :: 2021

Subjects :: Central Nervous System
Cancer Research
business.industry
Central nervous system
Lymphoma, T-Cell, Peripheral
Hematology
Purine Nucleosides
Pyrimidinones
Pharmacology
Forodesine
chemistry.chemical_compound
Regimen
medicine.anatomical_structure
Oncology
chemistry
Medicine
Humans
business
Ptcl nos

Tools